DUBLIN–(BUSINESS WIRE)–The “Facial Injectable Market, By Type, By Application, By End User and by Region – Global Forecast To 2023-2033” report has been added to ResearchAndMarkets.com’s offering.
The global facial injectable market size was USD 12.95 billion in 2022 and is expected to reach at USD 38.6 billion by 2033 with a CAGR of 10.45% during the forecast period 2023-2033.
The increasing acceptance of less invasive surgeries is one of the factors contributing to market growth. Additionally, introduction of new products is expected to drive market growth. However, facial injectable’s relative side effects and lack of permanence is expected to hinder the market growth.
The increasing acceptance of less invasive surgeries is expected to fuel the market. Invasive operations are rapidly being substituted with less invasive procedures.
For instance, the American Society of Plastic Surgeons estimates that approximately 18 million Americans will get cosmetic procedures in 2020. Additionally, around 16 million of these procedures included cosmetic materials, indicating a huge patient demand for less invasive treatment.
Launch of new products is expected to fuel the market growth. The urge for greater aesthetic appearance and the creation of new fillers has both significantly raised the demand for filler operations. There have been enhanced and more effective products introduced as a result of the increase in R&D activities for the creation of novel fillers.
The increased use of these fillers is mostly due to the introduction of new products with better cosmetic results. JUVEDERM VOLUX, the brand’s most recent addition to its range of facial fillers, was introduced by Allergan in April 2020. It was created for those who want a more defined chin and jawline.
Such product introductions have not only made innovative items more accessible to the general public. For instance, Revance Therapeutics, Inc. announced the launch of the RHA Dermal Filler Line in August 2020, the first and only FDA-approved dermal fillers in the United States for the treatment of dynamic face wrinkles and folds.
Market Dynamics
Drivers
- Growing use of harmful chemicals on the skin
- Rising skin problems
- Increasing consumption of tobacco
- Rising anxiety about ones looks
Restraint
- High cost of therapy
- Its adverse effects
- General lack of awareness
Opportunities
- Rising Investment Opportunities
- Favorable Policies
- Increasing end use
Trends
- New Product Launches
- Use of cutting-edge technology
- Innovative Methods and new techniques
Challenges
- Longer Duration Development
- Lack of awareness among individuals
- Lack of expert counseling
Companies Mentioned
- Ipsen
- Allergen Inc.
- Anika Therapeutics
- Merz Pharma
- Sinclair Pharma
- Galderma
- Bloomage Biotechnology Corporation limited
- Suneva Medical Inc.
- Medytox Inc.
- prollenium Medical Technologies
Market Segmentation
By Product (Revenue, USD Billion), 2022 – 2033
- Collagen & PMMA Microspheres
- Hyaluronic Acid (HA)
- Botulinum Toxin Type A
- Calcium Hydroxylapatite (CaHA)
- Poly-L-Lactic Acid (PLLA)
- Others
By Application (Revenue, USD Billion), 2022 – 2033
- Facial Line Correction
- Lip Augmentation
- Face Lift
- Acne Scar Treatment
- Lipoatrophy Treatment
- Others
By End User (Revenue, USD Billion), 2022 – 2033
- MedSpa
- Dermatology Clinics
- Hospitals
By Region (Revenue, USD Billion), 2022 – 2033
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/hjaj6n
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900